Display options
Cite
Ilié M, Hofman P. Pros: Can tissue biopsy be replaced by liquid biopsy?. Transl Lung Cancer Res. 2016;5(4):420-3doi: 10.21037/tlcr.2016.08.06.
Ilié, M., & Hofman, P. (2016). Pros: Can tissue biopsy be replaced by liquid biopsy?. Translational lung cancer research, 5(4), 420-3. https://doi.org/10.21037/tlcr.2016.08.06
Ilié, Marius, and Hofman, Paul. "Pros: Can tissue biopsy be replaced by liquid biopsy?." Translational lung cancer research vol. 5,4 (2016): 420-3. doi: https://doi.org/10.21037/tlcr.2016.08.06
Ilié M, Hofman P. Pros: Can tissue biopsy be replaced by liquid biopsy?. Transl Lung Cancer Res. 2016 Aug;5(4):420-3. doi: 10.21037/tlcr.2016.08.06. PMID: 27655109; PMCID: PMC5009092.
Copy Download .nbib Format: NLM
Share it on

Transl Lung Cancer Res. 2016 Aug;5(4):420-3. doi: 10.21037/tlcr.2016.08.06.

Pros: Can tissue biopsy be replaced by liquid biopsy?.

Translational lung cancer research

Marius Ilié, Paul Hofman

Affiliations

  1. Laboratory of Clinical and Experimental Pathology and Liquid Biopsy Laboratory, Pasteur Hospital, University of Nice Sophia Antipolis, Nice, France;; Institute for Research on Cancer and Ageing, Nice (IRCAN), Inserm U1081/UMR CNRS 7284, Team 3, Antoine Lacassagne Cancer Center, Nice, France;; Hospital-Integrated Biobank (BB-0033-00025), Pasteur Hospital, Nice, France;; University Hospital Federation OncoAge, CHU de Nice, University of Nice Sophia Antipolis, Nice, France.

PMID: 27655109 PMCID: PMC5009092 DOI: 10.21037/tlcr.2016.08.06

[No abstract available.]

Conflict of interest statement

Conflicts of Interest: P Hofman declares receiving honoraria from pharmaceutical (AstraZeneca, Roche, Novartis, Bristol Myers Squibb) and biotechnology (Qiagen, Janssen, Biocartis) companies for atten

References

  1. JAMA Oncol. 2016 Aug 1;2(8):1014-22 - PubMed
  2. Arch Pathol Lab Med. 2016 Aug;140(8):825-9 - PubMed
  3. PLoS One. 2014 Oct 31;9(10):e111597 - PubMed
  4. Oncotarget. 2016 Jan 5;7(1):1066-75 - PubMed
  5. Clin Cancer Res. 2016 Mar 1;22(5):1103-10 - PubMed
  6. J Clin Oncol. 2014 Feb 20;32(6):579-86 - PubMed
  7. Nature. 2012 Jun 28;486(7404):537-40 - PubMed
  8. Clin Cancer Res. 2015 Jul 15;21(14):3196-203 - PubMed
  9. N Engl J Med. 2012 Mar 8;366(10):883-92 - PubMed
  10. Nature. 2013 Sep 19;501(7467):355-64 - PubMed
  11. N Engl J Med. 2015 Apr 30;372(18):1689-99 - PubMed
  12. Nat Rev Clin Oncol. 2013 Aug;10(8):472-84 - PubMed
  13. Ann Oncol. 2016 Jun;27(6):1155-60 - PubMed
  14. Ann Transl Med. 2014 Nov;2(11):107 - PubMed
  15. Cancer Discov. 2015 Jul;5(7):713-22 - PubMed
  16. J Thorac Oncol. 2014 Sep;9(9):1345-53 - PubMed
  17. BMC Med Genomics. 2014 May 13;7:23 - PubMed
  18. Nature. 2013 May 2;497(7447):108-12 - PubMed
  19. Ann Oncol. 2012 Nov;23(11):2907-13 - PubMed
  20. Clin Cancer Res. 2011 Feb 15;17(4):827-35 - PubMed

Publication Types